Trials / Completed
CompletedNCT03278002
A Registry for Patients Taking Uptravi
Uptravi® (SelexiPag): tHe usErs dRug rEgistry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Actelion · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi. Participating patients will be followed prospectively for a maximum of 18 months from the date of enrollment into the registry.
Conditions
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2021-09-21
- Completion
- 2021-09-21
- First posted
- 2017-09-11
- Last updated
- 2025-03-30
Locations
85 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT03278002. Inclusion in this directory is not an endorsement.